EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers

Lisa van der Schee, Krijn J C Haasnoot iD, Sjoerd G Elias, Kim M Gijsbers, Yasser A Alderlieste, Yara Backes, Anne-Marie van Berkel, Femke Boersma, Frank Ter Borg, Emilie C H Breekveldt, Koen Kessels iD, Miriam Koopman und 15 weitere

Endoscopy · 01.07.2024 · 56 (07) · 484-493

DOI: 10.1055/a-2263-2841 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.07.2024. Verfasst von Lisa van der Schee und 26 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Neoplasm Staging, Lymphatic Metastasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of T1 colorectal cancer (CRC) has increased with the implementation of CRC screening programs. It is unknown whether the outcomes and risk models for T1 CRC based on non-screen-detected patients can be extrapolated to screen-detected T1 CRC. This study aimed to compare the stage distribution and oncologic outcomes of T1 CRC patients within and outside the screening program.

Methods

Data from T1 CRC patients diagnosed between 2014 and 2017 were collected from 12 hospitals in the Netherlands. The presence of lymph node metastasis (LNM) at diagnosis was compared between screen-detected and non-screen-detected patients using multivariable logistic regression. Cox proportional hazard regression was used to analyze differences in the time to recurrence (TTR), metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival. Additionally, the performance of conventional risk factors for LNM was evaluated across the groups.

Results

1803 patients were included (1114 [62%] screen-detected), with median follow-up of 51 months (interquartile range 30). The proportion of LNM did not significantly differ between screen- and non-screen-detected patients (12.6% vs. 8.9%; odds ratio 1.41; 95%CI 0.89–2.23); a prediction model for LNM performed equally in both groups. The 3- and 5-year TTR, MFS, and CSS were similar for patients within and outside the screening program. However, overall survival was significantly longer in screen-detected T1 CRC patients (adjusted hazard ratio 0.51; 95%CI 0.38–0.68).

Conclusions

Screen-detected and non-screen-detected T1 CRCs have similar stage distributions and oncologic outcomes and can therefore be treated equally. However, screen-detected T1 CRC patients exhibit a lower rate of non-CRC-related mortality, resulting in longer overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerNeoplasm StagingLymphatic MetastasisHumansMaleFemaleAgedMiddle AgedNetherlandsRisk FactorsRetrospective StudiesNeoplasm Recurrence, LocalProportional Hazards ModelsColonoscopySurvival Rate

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Pathology, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Gastroenterology and Hepatology, Deventer Hospital, Deventer, Netherlands.
  • Gastroenterology and Hepatology, Beatrixziekenhuis, Gorinchem, Netherlands.
  • Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands.

ORCID-Profile: Krijn J C Haasnoot, Koen Kessels, Esther Toes-Zoutendijk

Zitieren

APA

van der Schee, L., Haasnoot, K. J. C., Elias, S. G., Gijsbers, K. M., Alderlieste, Y. A., Backes, Y., van Berkel, A. M., Boersma, F., Ter Borg, F., Breekveldt, E. C. H., Kessels, K., Koopman, M., Lansdorp-Vogelaar, I., van Leerdam, M. E., Rasschaert, G., Schreuder, R. M., Schrauwen, R. W. M., Seerden, T. C. J., Spanier, M. B. W., …, & Moons, L. M. G. (2024). Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers. Endoscopy, 56(07), 484-493. https://doi.org/10.1055/a-2263-2841

Vancouver

van der Schee L, Haasnoot KJC, Elias SG, Gijsbers KM, Alderlieste YA, Backes Y, et al. Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers. Endoscopy. 2024;56(07):484-493. doi:10.1055/a-2263-2841

BibTeX
@article{vanderSchee2024,
  author = {van der Schee, Lisa and Haasnoot, Krijn J C and Elias, Sjoerd G and Gijsbers, Kim M and Alderlieste, Yasser A and Backes, Yara and van Berkel, Anne-Marie and Boersma, Femke and Ter Borg, Frank and Breekveldt, Emilie C H and Kessels, Koen and Koopman, Miriam and Lansdorp-Vogelaar, Iris and van Leerdam, Monique E and Rasschaert, Gertjan and Schreuder, Ramon-Michel and Schrauwen, Ruud W M and Seerden, Tom C J and Spanier, Marcel B W and Terhaar Sive Droste, Jochim S and Toes-Zoutendijk, Esther and Tuynman, Jurriaan B and Vink, Geraldine R and de Vos Tot Nederveen Cappel, Wouter H and Vleggaar, Frank P and Laclé, Miangela M and Moons, Leon M G},
  title = {Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {07},
  pages = {484--493},
  doi = {10.1055/a-2263-2841}
}
Kostenlos starten →